Articles and Blogs

As required by the Physician Payments Sunshine Act (“Sunshine Act”), by March 31, 2023, manufacturers of covered drugs, medical devices, biologicals and other medical supplies (“Applicable Manufacturers”), as well as applicable group purchasing organizations (“GPOs”), must report to the Centers for Medicare and Medicaid Services (“CMS”) payments made and other investment interests given in... READ MORE

As required by the Physician Payments Sunshine Act (“Sunshine Act”), by March 31, 2022, manufacturers of many drugs, medical devices, biologicals and other medical supplies, as well as applicable group purchasing organizations (“GPOs”), will report to CMS payments made and other investment interests given in 2021 to physicians, teaching hospitals and — for the... READ MORE

As required by the Physician Payments Sunshine Act (“Sunshine Act”)[i], manufacturers of many drugs, medical devices, biologicals and other medical supplies — as well as applicable group purchasing organizations (“GPOs”) — will soon complete (March 30, 2020) their reporting to the Centers for Medicare and Medicaid Services (“CMS”) of payments made and other investment... READ MORE

Recently, the Department of Health and Human Services Office of Inspector General (“OIG”) released findings of an audit of the Centers for Medicare and Medicaid Services (“CMS”) Open Payments program. The OIG audit revealed that of 11.9 million records published on the Open Payments website for 2015, only less than one percent were missing... READ MORE